Diagnosis: Chronic Migraine with Medication-Overuse Headache
This patient has chronic migraine that has transformed from episodic migraine, complicated by medication-overuse headache from daily paracetamol use. 1, 2
Differential Diagnoses
Primary Diagnosis: Chronic Migraine with Medication-Overuse Headache
- Chronic migraine criteria are met: ≥15 headache days/month for >2 months (she reports "almost 5x a week"), with original attacks fulfilling migraine without aura criteria (unilateral, throbbing, moderate-to-severe intensity, with nausea and photophobia, lasting 4-72 hours) 1, 2
- Medication-overuse headache is present: Regular paracetamol use ≥15 days/month for >2 months (she takes it "almost 5x a week" for the past 2 months) 1, 2
- The 10-year history of episodic migraine (3-4 times monthly) that recently transformed to near-daily headaches is the classic progression pattern 1
Other Differentials to Consider (but less likely):
- Tension-type headache: Ruled out by unilateral, throbbing quality and associated nausea/photophobia 2
- Secondary headache disorders: No red flags present (no fever, no focal neurological deficits, age <50, gradual onset, normal neurological exam) 2, 3
- Giant cell arteritis: Age <50 years excludes this 2
- Intracranial pathology: No progressive worsening over years, no awakening from sleep, no Valsalva aggravation 2, 3
Neuroimaging Decision
Neuroimaging is NOT indicated for this patient. 2, 3
Rationale Against Neuroimaging:
- No red flags present: No recent head trauma, no new neurological symptoms/signs, age <50, no thunderclap onset, no fever/neck stiffness, no altered consciousness, normal neurological examination 2, 3, 4
- Classic migraine pattern: 10-year history with typical migraine features that evolved to chronic migraine—this is an expected natural history 1
- Normal neurological examination: Cranial nerves intact, normal motor/sensory/cerebellar function, no papilledema 2
When Neuroimaging WOULD Be Indicated:
- New-onset headache after age 50 2, 3
- Atypical aura or persistent neurological deficits 5, 2
- Progressive worsening over weeks (not months/years) 3, 4
- Headache awakening from sleep or brought on by Valsalva/cough 2, 3
- Any abnormal neurological examination findings 2, 4
Management Plan
Step 1: Address Medication-Overuse Headache (CRITICAL FIRST STEP)
Immediate withdrawal of paracetamol is mandatory—this is the most important intervention. 1
- Explain to the patient: Her daily paracetamol use is perpetuating and worsening her headaches 1
- Abrupt discontinuation: Stop paracetamol completely (no tapering needed for non-opioid analgesics) 1
- Warn about withdrawal period: Headaches may temporarily worsen for 2-10 days before improvement begins 1
- Bridge therapy: Consider short course of prochlorperazine or metoclopramide for severe withdrawal symptoms 1, 6
Step 2: Initiate Prophylactic Therapy (START IMMEDIATELY)
Prophylactic treatment is mandatory for chronic migraine—this is not optional. 1, 2
First-Line Prophylactic Options:
Topiramate: The ONLY medication with proven efficacy in randomized controlled trials specifically for chronic migraine 1
Alternative first-line agents (evidence from episodic migraine, commonly used for chronic migraine):
Step 3: Optimize Acute Treatment (For Breakthrough Attacks)
Limit acute medication use to <10 days per month to prevent recurrence of medication-overuse headache. 1, 2
For Moderate-to-Severe Attacks:
- Triptans are first-line: Sumatriptan 50-100 mg, rizatriptan 10 mg, or eletriptan 40 mg 1, 6
- Combination therapy: NSAID (naproxen 500 mg) + triptan is more effective than either alone 6
- Antiemetic: Metoclopramide 10 mg or prochlorperazine 10 mg for nausea 1, 6
For Mild-to-Moderate Attacks:
- NSAIDs alone: Ibuprofen 400-800 mg, naproxen sodium 550 mg, or diclofenac potassium 50 mg 1, 6
- Avoid paracetamol: Given her history of medication overuse 1
Critical Medication Rules:
- Maximum 2 days per week for triptan use 1, 6
- Maximum 10 days per month for any acute medication 1, 2
- Implement headache diary: Track frequency to prevent medication overuse recurrence 1, 2
Step 4: Identify and Manage Triggers
- Smoking cessation: She is a current smoker—this is a modifiable risk factor and contraindication to ergot derivatives 1, 7
- Regular sleep schedule: Irregular sleep is a common trigger 1
- Stress management: Teaching profession is high-stress; consider biofeedback or relaxation techniques 8, 7
- Regular meals: Avoid fasting 1
- Limit caffeine: Excessive caffeine can contribute to medication-overuse headache 1
Step 5: Follow-Up Schedule
- 2 weeks: Assess medication withdrawal symptoms and tolerability of prophylactic medication 1
- 4-8 weeks: Evaluate prophylactic efficacy (expect 50% reduction in headache days) 1
- 3 months: If inadequate response, consider dose adjustment or alternative prophylactic agent 1
- Neurology referral: If first-line prophylactic fails or diagnosis remains uncertain 2
Contraception Counseling
Combined hormonal contraceptives (pills, patches, rings) are CONTRAINDICATED in this patient. 1
Contraindication Rationale:
- Migraine without aura + smoking: Combined hormonal contraceptives increase stroke risk in women with migraine, especially smokers 1
- Age >35 + smoking: Additional cardiovascular risk factor 1
- Even if she quits smoking, migraine without aura at age 30+ warrants caution with estrogen-containing contraceptives 1
Safe Contraceptive Options:
Progestin-only methods (SAFE and RECOMMENDED):
Non-hormonal methods (SAFE):
Critical Counseling Points:
- Avoid valproate if pregnancy possible: Valproate is teratogenic and should NOT be used in women of childbearing potential unless highly effective contraception is ensured 1
- If she chooses valproate for prophylaxis: Must use highly effective contraception (IUD or implant preferred) and sign informed consent regarding teratogenicity 1
- Topiramate is safer: Also has some teratogenic risk but less severe than valproate; still requires contraception 1
Common Pitfall to Avoid:
- Do NOT prescribe combined oral contraceptives to any woman with migraine who smokes or is >35 years old—this significantly increases stroke risk 1